{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T11:24:38Z","timestamp":1787397878389,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Jiangxi Provincial Natural Science Foundation of China","award":["No.20212BAB216033"],"award-info":[{"award-number":["No.20212BAB216033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04307-7","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:12:04Z","timestamp":1773677524000},"page":"3992-4006","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AURKB drives aggressive phenotype and clinicopathological progression in cholangiocarcinoma"],"prefix":"10.1007","volume":"28","author":[{"given":"Minglong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0330-711X","authenticated-orcid":false,"given":"Meidi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"issue":"1","key":"4307_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, et al. Cholangiocarcinoma. Nat Rev Dis Primers. 2021;7(1):65. https:\/\/doi.org\/10.1038\/s41572-021-00300-2.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"4307_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-022-00741-4","volume":"20","author":"TF Greten","year":"2023","unstructured":"Greten TF, Schwabe R, Bardeesy N, Ma L, Goyal L, Kelley RK, et al. Immunology and immunotherapy of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2023;20(6):349\u201365. https:\/\/doi.org\/10.1038\/s41575-022-00741-4.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"4307_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","volume":"72","author":"RK Kelley","year":"2020","unstructured":"Kelley RK, Bridgewater J, Gores GJ, Zhu AX. Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72(2):353\u201363. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.009.","journal-title":"J Hepatol"},{"issue":"1","key":"4307_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5391-0","volume":"19","author":"PL Labib","year":"2019","unstructured":"Labib PL, Goodchild G, Pereira SP. Molecular pathogenesis of cholangiocarcinoma. BMC Cancer. 2019;19(1):185. https:\/\/doi.org\/10.1186\/s12885-019-5391-0.","journal-title":"BMC Cancer"},{"issue":"2","key":"4307_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/hep.32624","volume":"77","author":"M Deng","year":"2023","unstructured":"Deng M, Ran P, Chen L, Wang Y, Yu Z, Cai K, et al. Proteogenomic characterization of cholangiocarcinoma. Hepatology. 2023;77(2):411\u201329. https:\/\/doi.org\/10.1002\/hep.32624.","journal-title":"Hepatology"},{"issue":"3","key":"4307_CR6","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jhep.2022.04.038","volume":"77","author":"C Raggi","year":"2022","unstructured":"Raggi C, Taddei ML, Rae C, Braconi C, Marra F. Metabolic reprogramming in cholangiocarcinoma. J Hepatol. 2022;77(3):849\u201364. https:\/\/doi.org\/10.1016\/j.jhep.2022.04.038.","journal-title":"J Hepatol"},{"key":"4307_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215980","volume":"553","author":"W Liao","year":"2023","unstructured":"Liao W, Feng Q, Liu H, Du J, Chen X, Zeng Y. Circular RNAs in cholangiocarcinoma. Cancer Lett. 2023;553:215980. https:\/\/doi.org\/10.1016\/j.canlet.2022.215980.","journal-title":"Cancer Lett"},{"issue":"5","key":"4307_CR8","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/hep.32424","volume":"75","author":"MJ Wu","year":"2022","unstructured":"Wu MJ, Shi L, Merritt J, Zhu AX, Bardeesy N. Biology of IDH mutant cholangiocarcinoma. Hepatology. 2022;75(5):1322\u201337. https:\/\/doi.org\/10.1002\/hep.32424.","journal-title":"Hepatology"},{"issue":"3","key":"4307_CR9","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jhep.2023.05.010","volume":"79","author":"JL Tomlinson","year":"2023","unstructured":"Tomlinson JL, Valle JW, Ilyas SI. Immunobiology of cholangiocarcinoma. J Hepatol. 2023;79(3):867\u201375. https:\/\/doi.org\/10.1016\/j.jhep.2023.05.010.","journal-title":"J Hepatol"},{"key":"4307_CR10","doi-asserted-by":"publisher","unstructured":"Pemigatinib for cholangiocarcinoma. Aust Prescr. 2022 Dec;45(6):216. https:\/\/doi.org\/10.18773\/austprescr.2022.078.","DOI":"10.18773\/austprescr.2022.078"},{"issue":"2","key":"4307_CR11","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.18632\/aging.102684","volume":"12","author":"M Nie","year":"2020","unstructured":"Nie M, Wang Y, Yu Z, Li X, Deng Y, Wang Y, et al. AURKB promotes gastric cancer progression via activation of CCND1 expression. Aging (Albany NY). 2020;12(2):1304\u201321. https:\/\/doi.org\/10.18632\/aging.102684.","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"4307_CR12","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1053\/j.gastro.2020.08.018","volume":"159","author":"B Chen","year":"2020","unstructured":"Chen B, Dragomir MP, Fabris L, Bayraktar R, Knutsen E, Liu X, et al. The long noncoding RNA CCAT2 induces chromosomal instability through BOP1-AURKB signaling. Gastroenterology. 2020;159(6):2146-2162.e33. https:\/\/doi.org\/10.1053\/j.gastro.2020.08.018.","journal-title":"Gastroenterology"},{"issue":"1","key":"4307_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05539-5","volume":"14","author":"C Garlapati","year":"2023","unstructured":"Garlapati C, Joshi S, Bhattarai S, Krishnamurthy J, Turaga RC, Nguyen T, et al. PLK1 and AURKB phosphorylate survivin differentially to affect proliferation in racially distinct triple-negative breast cancer. Cell Death Dis. 2023;14(1):12. https:\/\/doi.org\/10.1038\/s41419-022-05539-5.","journal-title":"Cell Death Dis"},{"key":"4307_CR14","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.7718","volume":"7","author":"B Wan","year":"2019","unstructured":"Wan B, Huang Y, Liu B, Lu L, Lv C. AURKB: a promising biomarker in clear cell renal cell carcinoma. PeerJ. 2019;7:e7718. https:\/\/doi.org\/10.7717\/peerj.7718.","journal-title":"PeerJ"},{"issue":"1","key":"4307_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-023-00707-1","volume":"14","author":"P Ma","year":"2023","unstructured":"Ma P, Hao Y, Wang W, Zhang YF, Yu KH, Wang WX. AURKB activates EMT through PI3K\/AKT signaling axis to promote ICC progression. Discov Oncol. 2023;14(1):102. https:\/\/doi.org\/10.1007\/s12672-023-00707-1.","journal-title":"Discov Oncol"},{"key":"4307_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2021.108376","volume":"787","author":"R Marima","year":"2021","unstructured":"Marima R, Hull R, Penny C, Dlamini Z. Mitotic syndicates Aurora Kinase B (AURKB) and mitotic arrest deficient 2 like 2 (MAD2L2) in cohorts of DNA damage response (DDR) and tumorigenesis. Mutat Res Rev Mutat Res. 2021;787:108376. https:\/\/doi.org\/10.1016\/j.mrrev.2021.108376.","journal-title":"Mutat Res Rev Mutat Res"},{"issue":"13","key":"4307_CR17","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1016\/j.celrep.2019.02.106","volume":"26","author":"Q Zhu","year":"2019","unstructured":"Zhu Q, Ding L, Zi Z, Gao S, Wang C, Wang Y, et al. Viral-mediated AURKB cleavage promotes cell segregation and tumorigenesis. Cell Rep. 2019;26(13):3657-3671.e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.02.106. (Erratum in: Cell Rep. 2019 Apr 30;27(5):1633-1636.).","journal-title":"Cell Rep"},{"issue":"10","key":"4307_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152557","volume":"215","author":"W Alafate","year":"2019","unstructured":"Alafate W, Zuo J, Deng Z, Guo X, Wu W, Zhang W, et al. Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma. Pathol Res Pract. 2019;215(10):152557. https:\/\/doi.org\/10.1016\/j.prp.2019.152557.","journal-title":"Pathol Res Pract"},{"key":"4307_CR19","doi-asserted-by":"publisher","first-page":"6947","DOI":"10.2147\/CMAR.S254250","volume":"12","author":"Z Wang","year":"2020","unstructured":"Wang Z, Yu Z, Wang GH, Zhou YM, Deng JP, Feng Y, et al. AURKB promotes the metastasis of gastric cancer, possibly by inducing EMT. Cancer Manag Res. 2020;12:6947\u201358. https:\/\/doi.org\/10.2147\/CMAR.S254250. (PMID: 32801915; PMCID: PMC7415439.).","journal-title":"Cancer Manag Res"},{"issue":"11","key":"4307_CR20","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1080\/00207454.2021.1914610","volume":"133","author":"Y Yang","year":"2023","unstructured":"Yang Y, Sheng Y, Sun D, Sun J, Li L, Sun L. AURKB promotes tumorigenesis and carboplatin resistance by regulating the ERK pathway in neuroblastoma cells. Int J Neurosci. 2023;133(11):1224\u201332. https:\/\/doi.org\/10.1080\/00207454.2021.1914610. (Epub 2023 Jul 17. PMID: 34396896.).","journal-title":"Int J Neurosci"},{"issue":"4","key":"4307_CR21","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.4.23","volume":"64","author":"H Wang","year":"2023","unstructured":"Wang H, Pan H, Huang X. AURKB enhances chromosomal remodeling of telomeric genes and accelerates tumorigenesis of uveal melanoma. Invest Ophthalmol Vis Sci. 2023;64(4):23. https:\/\/doi.org\/10.1167\/iovs.64.4.23. (PMID: 37079315; PMCID: PMC10132317.).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4307_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/11769343211057589","author":"J Xiao","year":"2021","unstructured":"Xiao J, Zhang Y. AURKB as a promising prognostic biomarker in hepatocellular carcinoma. Evol Bioinform Online. 2021. https:\/\/doi.org\/10.1177\/11769343211057589. (PMID: 34866894; PMCID: PMC8637395.).","journal-title":"Evol Bioinform Online"},{"issue":"Pt 1","key":"4307_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114904","volume":"245","author":"G Lv","year":"2023","unstructured":"Lv G, Shi Q, Zhang T, Li J, Kalashova J, Long Y, et al. 2-Phenoxy-3, 4\u2019-bipyridine derivatives inhibit AURKB-dependent mitotic processes by disrupting its localization. Eur J Med Chem. 2023;245(Pt 1):114904. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114904.","journal-title":"Eur J Med Chem"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04307-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04307-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04307-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T11:05:05Z","timestamp":1787396705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04307-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["4307"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04307-7","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest relevant to this study.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involving human participants was reviewed and approved by the Ethics Committee of The First Affiliated Hospital of Nanchang University, and written informed consent was obtained from all patients. All procedures involving animals were approved by the Animal Care and Use Committee of The First Affiliated Hospital of Nanchang University and conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has obtained informed consent from all participants.","order":3,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}